Aehr Test Systems Rally Delivers 680% One-Year Gain

Aehr Test Systems' stock has rallied almost 681% over the past year, Motley Fool reports, with a little over half of that increase occurring in 2026. The rally has been driven by a sequence of Aehr's own disclosed orders from its lead hyperscale customer: a company press release (via StockTitan/ACCESS Newswire) confirms an April 16, 2026 record $41 million production order for Sonoma ultra-high-power package-level test and burn-in systems tied to the customer's next-generation AI ASIC processors, with second-half 2026 bookings exceeding $92 million and system deliveries scheduled for summer 2026. Aehr's relatively small revenue base makes individual hyperscaler orders capable of producing outsized changes to backlog and realized revenue.

Semiconductor test equipment performs the final validation and stress-testing (burn-in) that prevents defective dies from entering supply channels; as demand for AI accelerators scales, test and burn-in capacity must scale in parallel. Aehr's Sonoma systems specifically address the extreme power density, high current, and multi-zone thermal management needed for next-generation AI ASICs -- a narrower niche than general-purpose semiconductor testing, which is part of why a single hyperscaler's order can move the stock so sharply.

For ML infrastructure and procurement teams, the practical implication is twofold: rising AI accelerator production raises absolute demand for validation throughput and burn-in testing, and reliance on a small set of specialized vendors like Aehr raises single-supplier risk for ramp schedules and yields. These are general industry patterns observed across past semiconductor cycles, not claims about any specific customer's internal plans.

Whether the $92 million in second-half 2026 bookings and the April order convert into recognized revenue on Aehr's coming quarterly disclosures; whether named or newly identified hyperscale customers place follow-on orders (Aehr's history shows repeat six- and eight-system deals from existing customers); and capacity-expansion moves from competing test-equipment vendors that would affect industry-wide validation supply.